换一批Cost-effectiveness Analysis of Two Therapeutic Regimens for Newly Diagnosed Smear-negative Pulmonary Tuberculosis
摘要Tuberculosis (TB) has a severe effect on human health and causes a huge economic burden[1]. Previous studies have demonstrated that patients with smear-negative pulmonary TB accounted for approximately 60％-70％ of the total pulmonary TB cases[2]. Therefore, it is extremely important to formulate safe, effective, and economic therapeutic regimens for patients with smear-negative pulmonary TB[3].
更多相关知识
DOI
10.3967/bes2018.085
发布时间
2018-10-15（万方平台首次上网日期，不代表论文的发表时间）
- 浏览18
- 被引1
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
